Sacubitrilat (INN; or LBQ657) is the active metabolite of the antihypertensive drug sacubitril,[1] which is used in the treatment of heart failure.[2]
References
- ^ Solomon SD. "HFpEF in the Future: New Diagnostic Techniques and Treatments in the Pipeline". Boston. p. 48. Retrieved 2012-01-26.
- ^ "FDA approves new drug to treat heart failure". Food and Drug Administration. 7 July 2015.
You must be logged in to post a comment.